Cabazitaxel

Cabazitaxel is a taxane and antineoplastic agent which is currently used in the therapy of castration-resistant metastatic prostate cancer after failure of docetaxel. Therapy with cabazitaxel has been associated with a low rate of serum enzyme elevations, but has not been linked to cases of clinically apparent acute liver injury, although it can cause severe hypersensitivity infusion reactions which in some instances can be associated with acute liver injury

A Anant Labs fabrica e fornece impurezas de Cabazitaxel de alta qualidade para o mercado global. Nossas impurezas EP de Cabazitaxel são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.